As of November 6, 2026, Nano Dimension Ltd. is a publicly traded company (Nasdaq: NNDM). The largest holder reporting an active stake on Schedule 13D is Murchinson Ltd., at 10.1%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Tang Capital Management, LLC (9.1%) (Schedule 13D/A, October 29, 2026).
Is this your company?
About to sign with, pay or invest in Nano Dimension Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Nano Dimension Ltd. a real, registered company?
- Nano Dimension Ltd. files with the SEC under CIK 1643303 (its SEC filings).
- Its shares are listed under the ticker NNDM on Nasdaq (SEC company record).
- Incorporated in L3; business address in Waltham, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Nano Dimension Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Moshe Rozenbaum, Chief Executive Officer (Form 8-K filed 2026-11-05). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Murchinson Ltd. (filed 2026-10-29).
Who are Nano Dimension Ltd.'s owners and officers?
Nano Dimension Ltd.: business address in Waltham, Massachusetts; industry Printed Circuit Boards (Form D, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-29 | Murchinson LTD. | 10.1% |
| Schedule 13G, 2026-08-21 | Tang Capital Management, LLC | 9.1% |
| Schedule 13D/A, 2026-07-27 | Tang Capital Management, LLC | 7.9% |
| Schedule 13D/A, 2026-07-22 | Oramed Pharmaceuticals Inc. | 3.3% |
| Schedule 13D/A, 2026-07-20 | Murchinson LTD. | 8.1% |
| Schedule 13D, 2026-06-30 | Tang Capital Management, LLC | 6.8% |
| Schedule 13D/A, 2026-06-23 | Murchinson LTD. | 9.6% |
| Schedule 13D/A, 2026-06-17 | Oramed Pharmaceuticals Inc. | 7.2% |
| Schedule 13D/A, 2026-05-21 | Murchinson LTD. | 7.4% |
| Schedule 13D/A, 2026-02-19 | Oramed Pharmaceuticals Inc. | 5.2% |
| Schedule 13D, 2026-01-29 | Oramed Pharmaceuticals Inc. | 5% |
| Schedule 13D/A, 2025-07-14 | Anson Funds Management LP | 4.2% |
Questions about who owns Nano Dimension Ltd.
Who owns Nano Dimension Ltd.?
On this page, 2 holders' latest ownership filings report 5% or more of Nano Dimension Ltd.: Murchinson LTD. (10.1%, Schedule 13D/A, filed 2026-10-29) and Tang Capital Management, LLC (9.1%, Schedule 13G, filed 2026-08-21).
Who are the largest shareholders of Nano Dimension Ltd.?
By the share each holder's latest filing reports, the largest holders of Nano Dimension Ltd. on this page are Murchinson LTD. (10.1%) and Tang Capital Management, LLC (9.1%).
When did Murchinson LTD. buy into Nano Dimension Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Murchinson LTD. on this page is the Schedule 13D/A, filed 2026-05-21, reporting 7.4%; its latest, Schedule 13D/A filed 2026-10-29, reports 10.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Nano Dimension Ltd.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Nano Dimension Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nano Dimension Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-11-05 | Moshe Rozenbaum | Chief Executive Officer | appointed | 2026-11-03 |
Which insiders own Nano Dimension Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 21,000,000 shares (10.6% of shares outstanding), held indirectly through By LP, on a joint filing (Form 3, 2026-10-26).
- Tang Capital Management LLC, a 10% owner: 21,000,000 shares (10.6% of shares outstanding), held indirectly through By LP, on a joint filing (Form 3, 2026-10-26).
- Nomis Bay Ltd.: 20,416,500 shares (10.3% of shares outstanding), held indirectly through By Nomis Bay Ltd. and 1 other, on a joint filing (Form 3, 2026-11-02).
- Murchinson Ltd., a 10% owner: 20,416,500 shares (10.3% of shares outstanding), held indirectly through By Nomis Bay Ltd. and 1 other, on a joint filing (Form 3, 2026-11-02).
- BPY Ltd.: 20,416,500 shares (10.3% of shares outstanding), held indirectly through By Nomis Bay Ltd. and 1 other, on a joint filing (Form 3, 2026-11-02).
Shares outstanding: 198,231,571 as of 2026-11-04, from the company's latest SEC cover page.
How much has Nano Dimension Ltd. raised?
No fundraising or offering filing from Nano Dimension Ltd. is on file with us.
Keep reading
More on Nano Dimension Ltd. and the records around it.
Nano Dimension Ltd. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Aug 2026
Companies that share a holder
- Murchinson Ltd. also filed stake reports on 2 other companies: Valion Bio, Inc. (Jul 2026), Pelthos Therapeutics Inc. (Nov 2025)
- Oramed Pharmaceuticals Inc. also filed stake reports on 2 other companies: Lifeward Ltd. (May 2026), Scilex Holding Co (Feb 2026)
- TANG CAPITAL MANAGEMENT, LLC also filed stake reports on 33 other companies: EyePoint, Inc. (Oct 2026), Skye Bioscience, Inc. (Oct 2026), Capricor Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/nano-dimension